| 1 |
MD_1_AOA_Medicamen
|
| 2 |
MD_1_MOA_Medicamen
|
| 3 |
MD_2_Certificate of Incorporation
|
| 4 |
MD_3_Certificate_of_Incorporation
|
| 5 |
MD_4_BM 26.12.2023 IPO Resolution
|
| 6 |
MD_4_EGM IPO Resolution with Explanatory Statement (17.01.2024)
|
| 7 |
MD_5_BR for RHP
|
| 8 |
MD_6_RFS DT 20.05.2024
|
| 9 |
Annual Report 2020-21
|
| 10 |
Annual Report 2021-22
|
| 11 |
Annual Report 2022-23
|
| 12 |
Audited Financial Statements – March 2024
|
| 13 |
MD 8 – Consent BRLM
|
| 14 |
MD 8 – Consent of Company Secretary (Varsha Bansal)
|
| 15 |
MD 8 – Consent from Bal Kishan Gupta (Chairman & Managing Director)
|
| 16 |
MD 8 – Consent from Banker to the Company
|
| 17 |
MD 8 – Consent from Banker to the Issue
|
| 18 |
MD 8 – Consent from CFO Lalit Gupta
|
| 19 |
MD 8 – Consent from Director Shailesh Gaur
|
| 20 |
MD 8 – Consent from Director Sachin Gupta
|
| 21 |
MD 8 – Consent from Independent Director Rajinder Kumar
|
| 22 |
MD 8 – Consent from Promoter Ashutosh Gupta
|
| 23 |
MD 8 – Consent from Rakesh Kumar
|
| 24 |
MD 8 – Consent from Whole Time Director Ashutosh Gupta
|
| 25 |
MD 8 – Consent of Director Sneh Gaur
|
| 26 |
MD 8 – Consent of Promoter Bal Kishan Gupta
|
| 27 |
MD 8 – Consent of RTA (KFin Technologies)
|
| 28 |
MD 8 – Consent of Underwriter
|
| 29 |
MD 8 – Legal Counsel Consent
|
| 30 |
MD 8 – Market Maker Consent
|
| 31 |
MD 8 – Sub Syndicate Consent
|
| 32 |
MD 9 – Consent from Statutory Auditor
|
| 33 |
MD 9 – Statement of Possible Special Tax Benefits
|
| 34 |
MD 10 – In-Principle Approval (LTC Medicamen)
|
| 35 |
MD_Terms and Conditions of Appointment of Independent Directors
|
